SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/2E3BE4DA9DC3323DE8444F07E8BA5EED0E7363A13D2A5DE725FD9A56D8BF0FB7E4FAE82834F255FE2AF206E32F951B1C>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/2E3BE4DA9DC3323DE8444F07E8BA5EED0E7363A13D2A5DE725FD9A56D8BF0FB7E4FAE82834F255FE2AF206E32F951B1C
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/2E3BE4DA9DC3323DE8444F07E8BA5EED0E7363A13D2A5DE725FD9A56D8BF0FB7E4FAE82834F255FE2AF206E32F951B1C
http://www.w3.org/2000/01/rdf-schema#comment
"Results indicate that the potency and specificity of sildenafil as an inhibitor of ABCB1 and ABCG2 is not sufficient to warrant further clinical testing of this agent in combination with anticancer drugs."
xsd:string
http://purl.uniprot.org/uniprot/#_7649F01E8B683A3D456844FB3C03144E0F7F4363C89C76D16706ED780E9EEDA1ED6AC16C0900886D409B39CDA0A8942B
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/2E3BE4DA9DC3323DE8444F07E8BA5EED0E7363A13D2A5DE725FD9A56D8BF0FB7E4FAE82834F255FE2AF206E32F951B1C
http://purl.uniprot.org/uniprot/W8DLN2
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/2E3BE4DA9DC3323DE8444F07E8BA5EED0E7363A13D2A5DE725FD9A56D8BF0FB7E4FAE82834F255FE2AF206E32F951B1C
http://purl.uniprot.org/uniprot/#_W8DLN2-mappedCitation-23422148
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/2E3BE4DA9DC3323DE8444F07E8BA5EED0E7363A13D2A5DE725FD9A56D8BF0FB7E4FAE82834F255FE2AF206E32F951B1C